Children and Adolescent Health Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Main campus, Baluchestan Blvd, Dr Hesabi Sq., Zahedan, Sistan and Baluchestan, Iran.
Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Clin Rheumatol. 2021 Aug;40(8):3115-3126. doi: 10.1007/s10067-021-05645-3. Epub 2021 Feb 12.
Rheumatoid arthritis (RA) is a complex inflammatory autoimmune disease with joint eruption, systemic manifestation, and numerous predisposing genetic factors. The P2X7 receptor is an essential ligand-gated channel that contributes to many physiological processes, especially inflammation. However, genetic variations can alter the P2X7 receptor function. Therefore, the present study aimed to explore the impact of P2X7 genetic polymorphisms and expression on susceptibility to RA in a sample of the Iranian population.
We enrolled 160 (145 female, 15 male) RA patients and 160 (142 female, 18 male) healthy individuals in this study. Genotyping was performed using tetra amplification refractory mutation system-polymerase chain reaction (TARMS-PCR) for rs1718119, rs2230912, rs2393799, rs28360457, rs35933842, and allele-specific PCR for rs1653624 and rs3751143. Furthermore, 44 new cases of RA and 48 healthy controls were recruited to investigate whether P2X7 mRNA expression is associated with RA susceptibility.
The results revealed that the rs2393799 significantly increased the risk of RA in all genetic models (p<0.05), while rs3751143 in codominant (CC vs. AA, OR=0.49, 95% CI=0.26-0.92), dominant (AC+CC, OR=0.59, 95% CI=0.37-0.94), C allele (OR=0.63, 95% CI=0.46-0.88), and rs2230912 in codominant (AG vs. AA, OR=0.56, 95% CI=0.34-0.94), dominant (AG+GG vs. AA, OR=0.59, 95% CI=0.35-0.99), and overdominant (AG vs. AA+GG, OR=0.57, 95% CI=0.33-0.98) significantly decreased the RA risk (p<0.05). Furthermore, the rs1718119 and rs1653624 were not associated with susceptibility of RA (p>0.05), and rs28360457 and rs35933842 were not polymorphic in our study. The mRNA expression level of P2X7 in both groups revealed that the P2X7 gene was significantly upregulated in RA (3.18±0.43) compared to healthy subjects (1.47±0.15, p<0.001).
Our results suggest that rs2393799, rs3751143, and rs2230912 variants of the P2X7 gene are associated with RA's susceptibility in a sample of the Iranian population. Also, P2X7 mRNA expression was higher in our new RA patients. The P2X7 receptor has been considered as a potential pharmacologic target in RA. Key Points • P2X7 variants (rs2393799, rs2230912, rs3751143) were associated with RA susceptibility in a sample of the Iranian population. • rs2393799 increases the risk of RA, while rs2230912 and rs3751143 decrease the risk of RA. • P2X7 expression was significantly upregulated in new RA patients compared to controls.
类风湿关节炎(RA)是一种复杂的炎症性自身免疫性疾病,具有关节发作、全身表现和许多潜在的遗传因素。P2X7 受体是一种重要的配体门控通道,参与许多生理过程,特别是炎症。然而,遗传变异可以改变 P2X7 受体的功能。因此,本研究旨在探讨伊朗人群中 P2X7 基因多态性和表达对 RA 易感性的影响。
我们纳入了 160 名(145 名女性,15 名男性)RA 患者和 160 名(142 名女性,18 名男性)健康个体进行了这项研究。使用四扩增难治性突变系统-聚合酶链反应(TARMS-PCR)对 rs1718119、rs2230912、rs2393799、rs28360457、rs35933842 进行基因分型,并用等位基因特异性 PCR 对 rs1653624 和 rs3751143 进行基因分型。此外,我们还招募了 44 名新的 RA 患者和 48 名健康对照者,以研究 P2X7 mRNA 表达是否与 RA 易感性相关。
结果表明,rs2393799 在所有遗传模型中均显著增加 RA 的发病风险(p<0.05),而 rs3751143 在共显性(CC 与 AA,OR=0.49,95%CI=0.26-0.92)、显性(AC+CC,OR=0.59,95%CI=0.37-0.94)、C 等位基因(OR=0.63,95%CI=0.46-0.88),以及 rs2230912 在共显性(AG 与 AA,OR=0.56,95%CI=0.34-0.94)、显性(AG+GG 与 AA,OR=0.59,95%CI=0.35-0.99)和超显性(AG 与 AA+GG,OR=0.57,95%CI=0.33-0.98)中显著降低 RA 的发病风险(p<0.05)。此外,rs1718119 和 rs1653624 与 RA 的易感性无关(p>0.05),而 rs28360457 和 rs35933842 在我们的研究中没有多态性。两组的 P2X7 基因 mRNA 表达水平显示,RA 组的 P2X7 基因表达水平明显高于健康对照组(3.18±0.43),健康对照组的 P2X7 基因表达水平为(1.47±0.15,p<0.001)。
我们的结果表明,P2X7 基因的 rs2393799、rs3751143 和 rs2230912 变体与伊朗人群的 RA 易感性有关。此外,我们新的 RA 患者中 P2X7 mRNA 表达更高。P2X7 受体已被认为是 RA 的潜在药物靶点。
P2X7 变体(rs2393799、rs2230912、rs3751143)与伊朗人群的 RA 易感性有关。
rs2393799 增加 RA 的发病风险,而 rs2230912 和 rs3751143 降低 RA 的发病风险。
与对照组相比,新的 RA 患者的 P2X7 表达显著上调。